US$ 21.53
fda green list import alert 66-80 glp-1 66-80: and Peptide Bulk API Now Detained at the Border FDA Issues 30 Warning Letters
Description
This once-weekly prefilled injector, designed for both type 2 diabetes and obesity, expands the drug's availability from the initial 2.5mg and 5mg vials to include six strengths (2.5, 5, 7.5, 10, 12.5, and 15mg)

Previous studies have suggested that therapeutic GLP-1 RAs given in combination with agents that lower blood glucose may increase the risk of hypoglycemia [13]
Together these data suggest a role for -cell GLP-1 production in the adaptation to metabolic disease

We're flattered
Smaller portions reduce nausea and make it easier to meet protein goals without feeling overly full
